Invention Grant
- Patent Title: Immunomodulating beta-1,6-D-glucans
-
Application No.: US15309313Application Date: 2015-05-08
-
Publication No.: US10266609B2Publication Date: 2019-04-23
- Inventor: James Michael Siedlecki , Gabriel Oscar Reznik , John James Kane , Hua Miao , Arthur F. Kluge , Ifat Rubin-Bejerano
- Applicant: Innate Biotherapeutics, LLC
- Applicant Address: US MA Newton
- Assignee: Innate Biotherapeutics, LLC
- Current Assignee: Innate Biotherapeutics, LLC
- Current Assignee Address: US MA Newton
- Agency: Foley Hoag LLP
- International Application: PCT/US2015/029916 WO 20150508
- International Announcement: WO2015/172040 WO 20151112
- Main IPC: C07H1/00
- IPC: C07H1/00 ; C08B37/00 ; C07H3/06 ; C07H5/04 ; C07H13/04 ; C07H15/04 ; C07H15/18 ; C07H15/203 ; C07H15/26 ; C07H19/044 ; C07H19/048
Abstract:
This invention relates to modifications of β-1,6-D-glucans, e.g., structures according to Formula (I), and the ability of these compositions to modulate an immune response.
Public/Granted literature
- US20170081428A1 IMMUNOMODULATING BETA-1,6-D-GLUCANS Public/Granted day:2017-03-23
Information query
